Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Seagen Inc (SGEN)
Seagen Inc (SGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 40,111,056
  • Shares Outstanding, K 187,698
  • Annual Sales, $ 1,962 M
  • Annual Income, $ -610,310 K
  • 60-Month Beta 0.48
  • Price/Sales 19.74
  • Price/Cash Flow N/A
  • Price/Book 14.83
Trade SGEN with:

Options Overview Details

View History
  • Implied Volatility 15.84% ( -6.43%)
  • Historical Volatility 15.96%
  • IV Percentile 20%
  • IV Rank 15.50%
  • IV High 59.24% on 09/29/22
  • IV Low 7.88% on 03/29/23
  • Put/Call Vol Ratio 2.91
  • Today's Volume 17,968
  • Volume Avg (30-Day) 16,214
  • Put/Call OI Ratio 2.85
  • Today's Open Interest 468,403
  • Open Int (30-Day) 391,232

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.72
  • Number of Estimates 8
  • High Estimate -0.63
  • Low Estimate -0.87
  • Prior Year -1.03
  • Growth Rate Est. (year over year) +30.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
194.55 +9.84%
on 08/23/23
214.00 -0.14%
on 09/22/23
+19.42 (+10.00%)
since 08/22/23
3-Month
190.67 +12.08%
on 06/29/23
214.00 -0.14%
on 09/22/23
+14.79 (+7.44%)
since 06/22/23
52-Week
116.08 +84.10%
on 12/06/22
214.00 -0.14%
on 09/22/23
+73.15 (+52.05%)
since 09/22/22

Most Recent Stories

More News
Hawkish Fed Comments Weigh on Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,320.06 (-0.23%)
SPY : 430.42 (-0.22%)
$DOWI : 33,963.84 (-0.31%)
DIA : 339.58 (-0.29%)
$IUXX : 14,701.10 (+0.05%)
QQQ : 357.91 (+0.01%)
NCLH : 15.66 (-7.45%)
RCL : 91.24 (-3.27%)
CCL : 14.05 (-2.77%)
TSN : 51.12 (-3.64%)
SCHL : 33.80 (-13.22%)
DE : 380.87 (-1.75%)
Lower Bond Yields Spark Mild Recovery in Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.88%. Stocks...

$SPX : 4,320.06 (-0.23%)
SPY : 430.42 (-0.22%)
$DOWI : 33,963.84 (-0.31%)
DIA : 339.58 (-0.29%)
$IUXX : 14,701.10 (+0.05%)
QQQ : 357.91 (+0.01%)
WDC : 45.14 (+1.58%)
META : 299.08 (+1.13%)
ON : 93.81 (+3.17%)
NVDA : 416.10 (+1.45%)
ASML : 587.10 (+0.86%)
AMAT : 136.17 (+0.72%)
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial

/PRNewswire/ -- Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") and Seagen Inc. (Nasdaq: SGEN) today announced positive topline...

SGEN : 213.70 (+3.54%)
Flee to Healthcare Stocks if Recession Rears its Head?

In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.

ABBV : 152.74 (-0.45%)
AMGN : 267.70 (-0.63%)
CTLT : 45.34 (-2.60%)
LLY : 550.54 (+0.07%)
XLV : 130.15 (-0.21%)
JNJ : 160.50 (-0.72%)
MOH : 334.59 (-0.05%)
NVO : 91.30 (+0.01%)
PFE : 32.69 (-0.49%)
SGEN : 213.70 (+3.54%)
UNH : 506.10 (+0.99%)
CRSP : 45.49 (-1.24%)
Advancements in Pancreatic Cancer Treatment: Biotech Innovations and Rising Optimism

USA News Group – According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for pancreatic cancer increased by 1% from the previous year to 12%. The...

ONCY : 2.16 (-1.37%)
ONC.TO : 2.91 (-1.36%)
SGEN : 213.70 (+3.54%)
MYGN : 16.61 (-0.95%)
ILMN : 132.44 (-0.67%)
BNTX : 104.64 (-1.68%)
Why Shares of Iovance Biotherapeutics Dropped Thursday

The biotech stock's lead therapy is looking at some competition.

SGEN : 213.70 (+3.54%)
GMAB : 36.08 (-1.12%)
IOVA : 4.87 (-3.28%)
Why Shares of Zai Lab Limited Were Jumping on Tuesday

Zai Lab's shares benefited from positive clinical trial news.

ZLAB : 24.47 (+2.04%)
SGEN : 213.70 (+3.54%)
GMAB : 36.08 (-1.12%)
Betting Big On Biotech: Six Undervalued Biotech Stocks To Keep On Your Radar

Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...

HALO : 39.57 (-0.85%)
KNSA : 16.64 (-2.92%)
ACAD : 23.56 (+0.68%)
HRMY : 36.28 (+1.57%)
AMPH : 45.51 (-0.33%)
INCY : 58.10 (-1.21%)
AGEN : 1.1800 (-0.84%)
NVS : 101.14 (-0.93%)
PFE : 32.69 (-0.49%)
SGEN : 213.70 (+3.54%)
MRK : 106.34 (-0.37%)
RXDX : 199.92 (+0.09%)
3 Fantastic Stocks to Buy in a New Bull Market

These stocks could be just the ticket if a sustained new bull market is beginning.

SGEN : 213.70 (+3.54%)
LLY : 550.54 (+0.07%)
NVO : 91.30 (+0.01%)
PFE : 32.69 (-0.49%)
3 Pharmaceutical Stocks to Buy and Hold for the Long Haul

Robust pipelines make these three pharmaceutical stocks solid choices for investors looking for stocks to buy and hold for long-term gains

PFE : 32.69 (-0.49%)
SGEN : 213.70 (+3.54%)
ABBV : 152.74 (-0.45%)
BMY : 58.90 (-0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Seagen, Inc., a biotechnology company, focuses on developing & commercializing therapies targeted for the treatment of cancer. Adcetris, a lead FDA approved marketed product at Seagen, is used for treating Hodgkin lymphoma, certain T-cell lymphomas, other cancers in the U.S., Europe & several countries....

See More

Key Turning Points

3rd Resistance Point 214.87
2nd Resistance Point 214.43
1st Resistance Point 214.07
Last Price 213.70
1st Support Level 213.27
2nd Support Level 212.83
3rd Support Level 212.47

See More

52-Week High 214.00
Last Price 213.70
Fibonacci 61.8% 176.59
Fibonacci 50% 165.04
Fibonacci 38.2% 153.49
52-Week Low 116.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar